Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 900.00 860.00 910.00 - 0.00 07:32:41
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16.3 -9.7 -17.3 - 669

Maxcyte Share Discussion Threads

Showing 701 to 720 of 750 messages
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older
DateSubjectAuthorDiscuss
14/5/2021
09:28
Awards? Games Workshop used to view them as a distraction and not attend: £2 to £110.
trident5
14/5/2021
07:19
As my granny used to say ;All good things.....
the white house
14/5/2021
07:11
Nasdaq listing registration submitted.
lomax99
13/5/2021
11:07
In good company CEO of the Year Award Company of the Year Award Capital Market Transaction of the Year Award Best Technology Award hTTp://www.mediscience-event.co.uk/nominations-overview/
pob69
12/5/2021
22:19
https://www.google.com/url?rct=j&sa=t&url=https://finance.yahoo.com/news/maxcyte-inc-lon-mxct-expected-045742668.html&ct=ga&cd=CAEYACoTNDU2OTkwMjczNDk3MTUzNDkyNjIcNjQ2MmE0NTY2MDg2ZmFhMDpjby51azplbjpHQg&usg=AFQjCNEm01a4lwYYsEHiVettaRCbnwoF4g Just double tap it!
assagai
12/5/2021
15:51
Fascinating thread by someone with a large twitter following hTTps://twitter.com/saharainvesting/status/1392492200978694144
pob69
10/5/2021
12:18
Practically a ramp from you trident! : ) Reckon you'll get some nasdaq news soon - complete guess of course. Whether or not it does anything to boost the price in this environment I dunno... but happy holding my position as a long term compounder
nimbo1
09/5/2021
21:14
Prospects look promising here, but the price does discount a lot of future uncertainty falling butter side up.
trident5
09/5/2021
20:35
I don't know why someone who concludes that you cannot invest in loss making companies is wasting his time looking at MXCT. There's loads of companies selling floor coverings that are going to be better prospects for whatever he is looking for.
donald pond
09/5/2021
15:15
Kenny clearly you like riling people - There are plenty of notes out there you can read which state the facts. Maxcyte's stake in CTX001 was just independently valued in a market transaction between vertex and crispr. royalties of 3-4% of a drug worth $11 billion which could be on the market in 2023. Here are some notes for you to consider - post negative views by all means but please at least make them reasonably well researched. hTTps://www.trinitydelta.org/research-notes/catching-an-unbroken-wave/ hxxps://www.getrevue.co/profile/moatslikekodak/issues/1-maxcyte-inc-mxct-368860
nimbo1
09/5/2021
15:10
Assagi, If you base your investments upon what others are doing, which I do not, then you should tend to pay more attention to what directors are doing. Therefore, are you not worried that the directors sold 755,000 shares at 700p in February this year? Or how about 575,000 shares sold by directors in July 2020 at 220p.
kenny
09/5/2021
15:01
A view apparently not shared by the latest crop of US funds on board. What do they know eh. Really worried now about my 104k shares.. but thanks for pointing out my error...and Baron Capital's error too...
assagai
09/5/2021
13:58
Kenny you can short it or just go back to obsessing over Raven property preference shares.
nimbo1
09/5/2021
13:56
Kenny another sector you have no idea about it seems. Every month this company adds new clients to its list, 1 in 3 of which is anticipated to give money to the company at a later date in milestone payments. Current potential milestone payments are £950m but that is that will go up it has gone up from £800m since last year. Add in the fact the gross profit margin on what they sell is over 90% and you are looking at a company that can only make money going forward. The fact MXCT is valued at 3 times only a third of the value of its probable current portfolio milestone payments is below average for the sector. CROs are on 3 times earnings alone for only providing services. So not over valued on any measure. Clearly you are not invested here so why are you posting rubbish?
pogue
09/5/2021
13:18
A view apparently not shared by the latest crop of US funds on board! What do they no eh?
assagai
09/5/2021
12:29
MXCT is a company capitalized at about £650m. All of that is hope value because: 1. MXCY has never made a profit and has accumulated losses of about $95m. 2. It finances itself by issuing new shares, annually. 3.The last balance sheet shows net assets of $33m. So, what is the hope value based upon. First that it obtains a Nasdaq listing which will maintain the share price at the crazy level it currently trades at – the greater fool theory. Second that it receives “milestoneR21; payments which if all those drugs proved successful is about $950m. However, it is stated that based upon past history, a third of the drugs may prove successful, so the realistic amount the company could receive is about $316m. Therefore, MXCT is capitalised at about three times its maximum potential earnings from its current portfolio, even when excluding its current annual operating expenses of $35m per annum. Investors seem to be confusing one-off milestone payments with repeating income. Admittedly, some years down the line there will be royalties on the medicines that prove to be successful but those royalties are far in the future. Also, are those royalties going to exceed its annual operating expenses? I think no one knows the answer. They seem to be good at public relations and selling their "story" of good times coming in the future, but will that rosy future transpire? Maybe this loss-making company will come good but even if it does, my view is that prodigious success is priced in already – and then some.
kenny
05/5/2021
15:54
He only ever posts negative comments on Mxct. He no doubt claims he’s being balanced to counteract the rampers. But when he never acknowledges anything good done by the company, he just comes across as the sort of boring sod, who when he enters the pub everyone sups up and leaves.
acuere
05/5/2021
15:16
Facebook recovered though and went on to be a massive success as I said the UK would never value it. Why would someone who holds be negative on going to another market that specialises in new tech to maximise the share price? Your post is odd for a holder. As to not effecting a share sentiment drives shares I don't know where else you maybe posting the same point or if others are doing similar it maybe a coordinated set of posts any thing is possible but again it goes back to why post what is a negative on such obvious good news.
pogue
05/5/2021
14:57
No they didn't - Facebook flopped on IPO and that was in the US. It's not a f deramp - how is my comment going to affect the share price? Grow up.
trident5
05/5/2021
13:47
Depends if you consider the company properly valued. A conservative minded UK investor does not value ground breaking new technology the same as the US so if you have a company with that tech then you go where the people will value it correctly. Are you so arrogant to assume you know the correct value of the company and US investors dont? Imagine if one of the big tech companies in the US like Facebook etc had listed in the UK. Investors like you would consider their lack of income as a red light and the company would fail in the US investors understood the value of their new way of making money and bet it would work out. Poor deramp try again.
pogue
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older
ADVFN Advertorial
Your Recent History
LSE
MXCT
Maxcyte
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210622 07:03:46